AMANDA FREMER: Open Payments
NPI 1003282609 · DUBOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 47 payments from 15 companies in 2025. Trend: 2023 $540 · 2024 $749 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $181 |
| ABBVIE INC. | 9 | $155 |
| Lilly USA, LLC | 5 | $152 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Exact Sciences Corporation | 4 | $77 |
| Dexcom, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $43 |
| Sonex Health, Inc. | 1 | $36 |
| Stryker Corporation | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: MOUNJARO, Ozempic, UBRELVY, Cologuard Collection Kit, Wegovy, AIRSUPRA, QULIPTA, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
